The Joint
NasdaqCM:JYNT
$ 8,21
+ $0,04 (0,49%)
8,21 $
+$0,04 (0,49%)
End-of-day quote: 03/20/2026

The Joint Stock Value

The current analyst rating for The Joint is Outperform.
Outperform
Outperform

The Joint Company Info

EPS Growth 5Y
-16,09%
Market Cap
$0,12 B
Long-Term Debt
$0,00 B
Short Interest
6,09%
Quarterly earnings
05/01/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
2010
Industry
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$9,00
9.62%
9.62
Last Update: 03/22/2026
Analysts: 3

Highest Price Target $12,00

Average Price Target $9,00

Lowest Price Target $9,00

In the last five quarters, The Joint’s Price Target has fallen from $27,23 to $16,38 - a -39,85% decrease. Two analysts predict that The Joint’s share price will increase in the coming year, reaching $9,00. This would represent an increase of 9,62%.

Top growth stocks in the health care sector (5Y.)

What does The Joint do?

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company uses a private pay, non-insurance, cash-based model. The company has created a growing network of modern, consumer-friendly chiropractic clinics operated or managed by franchisees and by it that employ licensed chiropractors. The company’s future growth strategy will focus on accelerating the development of its franchise base through the sale of additional franchises and through the continued support...
×